The Pharmacy and Poisons Board (PPB) has warned the public about fake diabetes medicine called Ozempic Pens (Semaglutide) being sold illegally in Kenya.
PPB stated clearly that these drugs are not allowed for use in Kenya.
This warning came after INTERPOL reported that Apidra Solostar pens (glulisine), which are used for diabetes treatment, were falsely labeled as Ozempic Pens.
“Ozempic Pens are not approved or allowed by the Board to be sold in Kenya,” PPB emphasized.
This means any products claiming to be Ozempic Pens are illegal, and the Board cannot guarantee they are safe, good quality, or effective.
PPB has started quick actions and is closely watching to find out if these fake Ozempic Pens are in Kenya.
They have asked the public and healthcare workers to avoid trading or using these unauthorized products.
The Board has restated its commitment to keeping people healthy.
They want everyone to watch out for and quickly report any bad or fake health products or if someone has a bad reaction to medicine.
PPB said they are working to make sure only safe and good medicines are available in Kenya.
This warning is important for everyone to know about the risks of fake medicines and why strict rules are needed to keep the healthcare system honest and safe.
Mass IT Outage Hits Companies Around The World As Planes Grounded And Train Services Affected
